- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07943338
Study on Patients' Assessment of the Quality of Care During Their Treatment for Cholecystectomies at Limoges University Hospital (SATISCHOL)
A Prospective Observational Study on Patients' Assessment of the Quality of Care During Their Treatment for Cholecystectomies at Limoges University Hospital
SATISCHOL is a prospective, monocentric observational study designed to assess pain management and quality of care in patients undergoing elective cholecystectomy at Limoges University Hospital, France.
The primary objective is to assess the proportion of patients reporting a visual analogue scale (VAS) pain score below 4 two hours after surgery, in association with the occurrence of no postoperative complication or a grade I early postoperative complication according to the Clavien-Dindo classification, within four weeks after surgery.
Secondary objectives include assessing early postoperative pain, describing postoperative complications and intraoperative pain management techniques, and evaluating changes in patients' quality of life using the Gastrointestinal Quality of Life Index (GIQLI) and EQ-5D-5L questionnaires. Patient-reported experience will also be assessed using a study-specific questionnaire (PREMS).
A total of 70 participants are expected to be enrolled. Patients will be followed for approximately 3 to 6 weeks after surgery.
Study Overview
Status
Detailed Description
Cholecystectomy is one of the most frequently performed surgical procedures worldwide, both in elective and emergency settings. At Limoges University Hospital, 146 elective laparoscopic cholecystectomies were performed in 2024.
Cholecystectomy is indicated for the treatment of various biliary tract conditions, including biliary colic, acute or chronic cholecystitis, gallbladder polyps, gallstone pancreatitis, cholangitis and common bile duct stones.
Laparoscopic cholecystectomy, with achievement of the critical view of safety, is the standard surgical approach.
Patient-reported outcome measures (PROMs) and postoperative satisfaction have become increasingly important in the assessment of surgical outcomes and are considered key components of patient-centred care.
This study aims to assess pain management and quality of care during elective cholecystectomy at Limoges University Hospital.
Postoperative pain will be assessed using the visual analogue scale (VAS) two hours after surgery. Postoperative complications will be recorded and classified according to the Clavien-Dindo classification up to four weeks after surgery.
Intraoperative pain management techniques, including trocar-site infiltration, diaphragmatic dome infiltration with local anaesthetic and transversus abdominis plane (TAP) block, will also be documented.
Quality of life will be assessed before surgery (T0) and at postoperative follow-up (T2) using the GIQLI and EQ-5D-5L questionnaires. Patient experience will be evaluated at T2 using a study-specific PREMS questionnaire.
Data will be collected prospectively from clinical records and patient-completed questionnaires administered during the preoperative consultation and at the postoperative follow-up consultation, approximately 3 to 6 weeks after surgery.
The study is expected to contribute to the continuous improvement of pain management and quality of care for patients undergoing cholecystectomy at Limoges University Hospital.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Niki CHRISTOU, Professor
- Phone Number: 05 55 05 55 55
- Email: niki.christou@chu-limoges.fr
Study Contact Backup
- Name: Oumar SECK
- Email: cheikhououmar.seck@chu-limoges.fr
Study Locations
-
-
-
Limoges, France, 87042
- Recruiting
- Chu Limoges
-
Contact:
- Niki CHRISTOU, Professor
- Phone Number: 05 55 05 55 55 0555058630
- Email: niki.christou@chu-limoges.fr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Patients undergoing elective cholecystectomy, laparoscopic surgery or minimally invasive surgery.
Description
Inclusion Criteria:
- Age 18 years or older.
- Patients undergoing elective cholecystectomy.
- Patients undergoing laparoscopic surgery or minimally invasive surgery, including conversion to open laparotomy when necessary.
- Patients able to complete questionnaires independently or with the assistance of a caregiver.
- Patients covered by a health insurance scheme.
- Patients who have not objected to participation in the study.
Exclusion Criteria:
- Patients undergoing emergency surgery.
- Patients undergoing cholecystectomy when gallbladder removal is not the primary purpose of the surgical procedure.
- Patients with a history of chronic gastrointestinal disease.
- Patients with known gallbladder cancer.
- Patients scheduled for open laparotomy.
Study Plan
How is the study designed?
Design Details
- Observational Models: COHORT
- Time Perspectives: PROSPECTIVE
Cohorts and Interventions
Group / Cohort |
|---|
|
Patients undergoing elective cholecystectomy
Adult patients undergoing elective cholecystectomy at Limoges University Hospital |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proportion of patients with a visual analogue scale (VAS) pain
Time Frame: From two hours after surgery to four weeks postoperatively.
|
Proportion of patients with a visual analogue scale (VAS) pain score below 4 two hours after cholecystectomy, associated with the occurrence of no postoperative complication or a grade I early postoperative complication according to the Clavien-Dindo classification, within four weeks after surgery. |
From two hours after surgery to four weeks postoperatively.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proportion of patients with a VAS pain score
Time Frame: Two hours after surgery.
|
Proportion of patients with a VAS pain score below 4 two hours after cholecystectomy. |
Two hours after surgery.
|
|
Proportion of patients experiencing early postoperative complications
Time Frame: Up to four weeks after surgery.
|
Proportion of patients experiencing early postoperative complications, classified according to the Clavien-Dindo classification. |
Up to four weeks after surgery.
|
|
Description of intraoperative pain management techniques
Time Frame: During surgery
|
Assessment of intraoperative analgesic techniques used during surgery, including: local anaesthetic infiltration at trocar insertion sites, local anaesthetic infiltration of the diaphragmatic dome, transversus abdominis plane (TAP) block . For each technique performed, the type of local anaesthetic used and the administered dose will be recorded, where applicable. |
During surgery
|
|
Change in the total Gastrointestinal Quality of Life Index (GIQLI) score
Time Frame: Preoperative assessment (T0) and postoperative assessment at 3 to 6 weeks (T2).
|
Change in the total Gastrointestinal Quality of Life Index (GIQLI) score between baseline (T0) and postoperative follow-up (T2) |
Preoperative assessment (T0) and postoperative assessment at 3 to 6 weeks (T2).
|
|
Change in the EQ-5D-5L visual analogue scale (VAS)
Time Frame: Preoperative assessment (T0) and postoperative assessment at 3 to 6 weeks (T2).
|
Change in the EQ-5D-5L visual analogue scale (VAS), corresponding to the patient's self-rated health status today, between baseline (T0) and postoperative follow-up (T2). |
Preoperative assessment (T0) and postoperative assessment at 3 to 6 weeks (T2).
|
|
Description of patient-reported experience using the study-specific PREMS questionnaire
Time Frame: Postoperative assessment at 3 to 6 weeks (T2)
|
Description of patient-reported experience using the study-specific PREMS questionnaire, analysed item by item. |
Postoperative assessment at 3 to 6 weeks (T2)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Niki CHRISTOU, Professor, University Hospital, Limoges
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Pain
- Neurologic Manifestations
- Nervous System Diseases
- Postoperative Complications
- Pathologic Processes
- Digestive System Diseases
- Neurobehavioral Manifestations
- Biliary Tract Diseases
- Gallbladder Diseases
- Perceptual Disorders
- Pathological Conditions, Signs and Symptoms
- Signs and Symptoms
- Pain, Postoperative
- Cholecystitis
- Agnosia
- Cholelithiasis
Other Study ID Numbers
- 87RI24_0064 (SATISCHOL)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Individual participant data collected during this study will not be made publicly available. Data will be handled in accordance with applicable data protection regulations and institutional policies.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.